An integrase inhibitor-based antiretroviral regimen is noninferior to a boosted protease inhibitor-based regimen in treatment ...

An estimated 10,000 people are about to lose access to their HIV medication as the Florida Department of Health makes cuts to ...

Using participant skin cells reprogrammed into neurons, Weill Cornell Medicine researchers have identified genetic signatures ...

The immune system remains seriously out-of-whack – in an inflammatory state of overactivation and impaired functionality – ...

In patients with HIV infection on rifampicin TB therapy, twice-daily bictegravir/emtricitabine/tenofovir alafenamide results ...

BEAVERTON, OR, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Sedia Biosciences Corporation, a leading developer ...

Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial insurance plans, the drugmaker's CEO ...

Thousands in Florida who rely on the AIDS Drug Assistance Program will see their coverage cut or their medication changed, ...

Seeking to prevent the spread of HIV, Unitaid is providing $31 million to South Africa and Zambia in hopes of widening access ...